A

Alexion

Global biopharmaceuticals focusing on rare diseases

Head of Business Planning & Performance

Business OperationsUpdated on Nov 14
Full-timeDublin, IrelandNo salary listedIn-person

About the Job

Requirements

  • Requires 5–8 years of experience in business planning, performance, strategy, finance, or business management in a senior role as part of a leadership team, ideally in a trusted-adviser or business-partnering capacity.
  • Requires experience in senior roles within the Quality Function of a Contract Laboratory, Contract Manufacturing Operations, or Quality Operations.
  • Requires an excellent understanding of regulatory, compliance, manufacturing, and pharmaceutical development.
  • Requires strong experience with budgets, forecasts, headcount, and resource planning, with sound financial and commercial judgement.
  • Requires experience leading or coordinating a Medium-Term Plan (MTP) or equivalent planning process.
  • Requires a track record of overseeing or delivering major projects or programmes and holding leaders to account for delivery.
  • Requires stakeholder-management and influencing skills at senior leadership level, including across a complex, global, and regulated organisation.
  • Requires experience preparing information and recommendations for senior leaders.
  • Requires the ability to identify themes across teams and turn information into clear actions.
  • Requires strong analytical and communication skills and discretion when handling confidential information.
  • Requires a degree in science, engineering, business, finance, economics, analytics, or a related discipline.

Responsibilities

  • Act as a trusted adviser and thought partner to the Head of Quality Operations, anticipating priorities, shaping the agenda, and protecting leadership time and focus.
  • Run the Quality Operations Leadership Team’s planning and performance calendar, including agendas, papers, decisions, and actions.
  • Track leadership decisions and actions through completion, ensuring each has a clear owner and due date.
  • Identify and escalate material issues requiring the Head of Quality Operations’ attention or decision, with a clear recommendation.
  • Prepare Quality Operations leaders for enterprise meetings and discussions, and coordinate commitments from senior leaders and stakeholders.
  • Lead the Quality Operations contribution to the Medium-Term Plan and annual business plan.
  • Own the Quality Operations budget and forecasting process in partnership with Finance, providing information on spending, forecasts, risks, and opportunities.
  • Manage headcount planning and control, including resource requests, vacancies, and workforce plans, in partnership with HR and Finance.
  • Help leaders decide where to invest, reduce, stop, or change activity, and clarify the trade-offs.
  • Handle other finance matters, including business cases, investment requests, external spend, and financial governance requirements.
  • Provide a unified view of Quality Operations performance and customer and stakeholder feedback.
  • Ensure consistent linkage between the Quality Operations Strategy & Performance and the overall Alexion Operations Strategy and Objectives.
  • Bring together team performance, the Batch-to-Release scorecard, financial information, risks, customer feedback, and transformation progress.
  • Identify function-wide performance or customer themes and bring them to the attention of the appropriate leaders.
  • Ensure important issues have a clear owner, action, and due date.
  • Gain strategic insight from AstraZeneca, including enterprise priorities, strategic direction, and emerging trends, and translate it into implications and recommendations for Quality Operations.
  • Partner with AstraZeneca Quality on business planning, aligning Quality Operations plans, budgets, and priorities with AstraZeneca Quality planning cycles and objectives.
  • Represent Quality Operations in AstraZeneca Quality planning forums, and coordinate inputs, requests, and commitments between the organisations.
  • Share Quality Operations insight and performance with AstraZeneca Quality so both teams work from a consistent view.
  • Maintain oversight of major projects and programmes across Quality Operations, including implementation of the new Quality operating model, with a unified view of scope, milestones, resources, risks, dependencies, and benefits.
  • Ensure initiatives have clear owners, plans, measures, resources, and benefits.
  • Challenge project leads constructively, and raise delivery risks, slippage, and resource conflicts early with options for leaders to consider.
  • Help leaders prioritise when delivering change competes with running the current business.
  • Establish proportionate project governance, including regular delivery reviews with the Leadership Team.
  • Ensure Quality Operations communicates a unified view of its performance, plans, risks, and priorities.
  • Build and maintain connections between Quality Operations and key stakeholders across Alexion Rare Disease Unit and AstraZeneca, including Finance, HR, and project and programme leaders.
  • Make performance reporting, planning, and governance clear, useful, and proportionate.
  • Challenge poor-quality information, unclear conclusions, and unnecessary reporting.
  • Use data, analytics, and AI-supported tools responsibly, applying appropriate human judgement.

Desired Qualifications

  • Experience implementing a new operating model or major transformation.
  • Experience managing large or complex budgets.
  • Experience using customer and stakeholder feedback to improve performance.
  • Experience with performance, financial, portfolio, or enterprise planning systems.
  • A project, programme, or change management qualification.
  • Familiarity with data integrity, analytics, and responsible use of AI.

About the Company

Alexion

Global biopharmaceuticals focusing on rare diseases

Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1992

Recently Posted Jobs

Explore more opportunities at Alexion

See more jobs